Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Rose KL, Sherman PM, Cooke-Lauder J, Mawani M, Benchimol EI, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.

2.

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.

Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.

3.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.

Nguyen GC, Targownik LE, Singh H, Benchimol EI, Bitton A, Murthy SK, Bernstein CN, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S68-S72. doi: 10.1093/jcag/gwy051. Epub 2018 Nov 2.

4.

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.

5.

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, Murthy SK, Lee K, Cooke-Lauder J, Otley AR.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.

6.

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Kuenzig ME, Lee L, El-Matary W, Weizman AV, Benchimol EI, Kaplan GG, Nguyen GC, Bernstein CN, Bitton A, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.

7.

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.

Kuenzig ME, Benchimol EI, Lee L, Targownik LE, Singh H, Kaplan GG, Bernstein CN, Bitton A, Nguyen GC, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.

8.

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.

Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.

9.

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Siddiq S, Windsor JW, Carroll MW, Coward S, El-Matary W, Griffiths AM, Jones JL, Kuenzig ME, Lee L, Mack DR, Mawani M, Otley AR, Singh H, Targownik LE, Weizman AV, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.

10.

The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.

Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix L, Tennakoon A, Zubieta AA, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Peña-Sánchez JN, Kaplan G.

Inflamm Bowel Dis. 2019 Jun 18. pii: izz063. doi: 10.1093/ibd/izz063. [Epub ahead of print]

PMID:
31211836
11.

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.

Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD, Singh H, Targownik L, Taljaard M.

Gut. 2019 Jun 12. pii: gutjnl-2019-318440. doi: 10.1136/gutjnl-2019-318440. [Epub ahead of print]

12.

Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data.

Murthy SK, Shukla T, Antonova L, Belair MA, Ramsay T, Gallinger Z, Nguyen GC, Benchimol EI.

BMC Gastroenterol. 2019 Jan 21;19(1):13. doi: 10.1186/s12876-018-0924-6.

13.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

14.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

15.

Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.

Targownik LE, Benchimol EI, Bernstein CN, Singh H, Lix L, Tennakoon A, Leung S, Aviña A, Coward S, Jones J, Kaplan G, Murthy SK, Nguyen GC, Peña-Sánchez JN.

Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31246-1. doi: 10.1016/j.cgh.2018.11.003. [Epub ahead of print]

PMID:
30448599
16.

Appropriateness of Biologics in the Management of Crohn's Disease Using RAND/UCLA Appropriateness Methodology.

Weizman AV, Nguyen GC, Seow CH, Targownik L, Murthy SK, Boland K, Afzal NM, Khanna R, Jones J, Afif W, Halder S, Reinglas J, Fowler S, Huang V, Kaplan GG, Melmed GY.

Inflamm Bowel Dis. 2019 Jan 10;25(2):328-335. doi: 10.1093/ibd/izy333.

PMID:
30346529
17.

Automated generation of immature dendritic cells in a single-use system.

Kozbial A, Bhandary L, Collier BB, Eickhoff CS, Hoft DF, Murthy SK.

J Immunol Methods. 2018 Jun;457:53-65. doi: 10.1016/j.jim.2018.03.010. Epub 2018 Apr 3.

18.

Temporal trends in postcolonoscopy colorectal cancer rates in 50- to 74-year-old persons: a population-based study.

Murthy SK, Benchimol EI, Tinmouth J, James PD, Ducharme R, Rostom A, Dubé C.

Gastrointest Endosc. 2018 May;87(5):1324-1334.e4. doi: 10.1016/j.gie.2017.12.027. Epub 2018 Jan 6.

PMID:
29317271
19.

Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists.

Gallinger ZR, Rumman A, Murthy SK, Nguyen GC.

Endosc Int Open. 2017 Oct;5(10):E974-E979. doi: 10.1055/s-0043-117944. Epub 2017 Oct 4.

20.

Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy.

Murthy SK, Dubé C, Rostom A, Benchimol EI, Ducharme R, Sutradhar R, Rabeneck L, Paszat L, Tinmouth J.

Endoscopy. 2017 Dec;49(12):1229-1236. doi: 10.1055/s-0043-117402. Epub 2017 Sep 15.

PMID:
28915524
21.

Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1485. doi: 10.1038/ajg.2017.271. Epub 2017 Aug 22.

22.

Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208. Epub 2017 Jul 25. Erratum in: Am J Gastroenterol. 2017 Sep;112(9):1485.

23.

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.

Nguyen GC, Boland K, Afif W, Bressler B, Jones JL, Weizman AV, Fowler S, Halder S, Huang VW, Kaplan GG, Khanna R, Murthy SK, Ruel J, Seow CH, Targownik LE, Chawla T, Guimaraes L, Fernandes A, Saleh S, Melmed GY.

Inflamm Bowel Dis. 2017 Jun;23(6):858-865. doi: 10.1097/MIB.0000000000001152.

PMID:
28509817
24.

High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.

Murthy SK, James PD, Antonova L, Chalifoux M, Tanuseputro P.

PLoS One. 2017 May 12;12(5):e0177211. doi: 10.1371/journal.pone.0177211. eCollection 2017.

25.

Circulating Endothelial Cell Quantification by Microfluidics Chip in Pulmonary Arterial Hypertension.

Sallmon H, Hatch A, Murthy SK, Plouffe BD, Hansmann G.

Am J Respir Cell Mol Biol. 2017 May;56(5):680-682. doi: 10.1165/rcmb.2017-0026LE. No abstract available.

26.

Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.

Nguyen GC, Murthy SK, Bressler B, Lam MCW, Alali A, Toumi A, Reinglas J, Rampersad A, Weizman AV, Afif W; CINERGI group.

Inflamm Bowel Dis. 2017 May;23(5):695-701. doi: 10.1097/MIB.0000000000001068.

PMID:
28426451
27.

Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.

Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM, Mack DR, Jacobson K, Mojaverian N, Tanyingoh D, Cui Y, Nugent ZJ, Coulombe J, Targownik LE, Jones JL, Leddin D, Murthy SK, Kaplan GG.

Am J Gastroenterol. 2017 Jul;112(7):1120-1134. doi: 10.1038/ajg.2017.97. Epub 2017 Apr 18.

28.

Electrically-Actuated Valves for Woven Fabric Lateral Flow Devices.

Narahari T, Dendukuri D, Murthy SK.

Anal Chem. 2017 Apr 18;89(8):4671-4679. doi: 10.1021/acs.analchem.7b00275. Epub 2017 Apr 4.

PMID:
28337914
29.

Enabling Microfluidics: from Clean Rooms to Makerspaces.

Walsh DI 3rd, Kong DS, Murthy SK, Carr PA.

Trends Biotechnol. 2017 May;35(5):383-392. doi: 10.1016/j.tibtech.2017.01.001. Epub 2017 Feb 3. Review.

30.

EUS-guided paclitaxel injection as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation before surgery for localized or locoregional esophageal cancer: a multicenter prospective randomized trial.

DeWitt JM, Murthy SK, Ardhanari R, DuVall GA, Wallner G, Litka P, Daugherty C, Fowers K.

Gastrointest Endosc. 2017 Jul;86(1):140-149. doi: 10.1016/j.gie.2016.11.017. Epub 2016 Nov 24.

PMID:
27890801
31.

Fluorescence-based lateral flow assays for rapid oral fluid roadside detection of cannabis use.

Plouffe BD, Murthy SK.

Electrophoresis. 2017 Feb;38(3-4):501-506. doi: 10.1002/elps.201600075. Epub 2016 Nov 28.

PMID:
27862053
32.

Suspension-based differentiation of adult mesenchymal stem cells toward chondrogenic lineage.

Adeniran-Catlett AE, Beguin E, Bozal FK, Murthy SK.

Connect Tissue Res. 2016 Nov;57(6):466-475. Epub 2015 Dec 29.

PMID:
26713781
33.

One step antibody-mediated isolation and patterning of multiple cell types in microfluidic devices.

Bavli D, Ezra E, Kitsberg D, Vosk-Artzi M, Murthy SK, Nahmias Y.

Biomicrofluidics. 2016 Mar 21;10(2):024112. doi: 10.1063/1.4944741. eCollection 2016 Mar.

34.

Ultra-High-Throughput Sample Preparation System for Lymphocyte Immunophenotyping Point-of-Care Diagnostics.

Walsh DI 3rd, Murthy SK, Russom A.

J Lab Autom. 2016 Oct;21(5):706-12. doi: 10.1177/2211068216634003. Epub 2016 Feb 26.

PMID:
26920576
35.

Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.

Calvier L, Legchenko E, Grimm L, Sallmon H, Hatch A, Plouffe BD, Schroeder C, Bauersachs J, Murthy SK, Hansmann G.

Heart. 2016 Mar;102(5):390-6. doi: 10.1136/heartjnl-2015-308365.

PMID:
26869635
36.

Effects of early adolescent environmental enrichment on cognitive dysfunction, prefrontal cortex development, and inflammatory cytokines after early life stress.

do Prado CH, Narahari T, Holland FH, Lee HN, Murthy SK, Brenhouse HC.

Dev Psychobiol. 2016 May;58(4):482-91. doi: 10.1002/dev.21390. Epub 2015 Dec 21.

PMID:
26688108
37.

Accelerated adipogenic differentiation of hMSCs in a microfluidic shear stimulation platform.

Adeniran-Catlett AE, Weinstock LD, Bozal FK, Beguin E, Caraballo AT, Murthy SK.

Biotechnol Prog. 2016 Mar;32(2):440-6. doi: 10.1002/btpr.2211. Epub 2015 Dec 16.

PMID:
26587686
38.

Microfluidic Sample Preparation for Single Cell Analysis.

Hosic S, Murthy SK, Koppes AN.

Anal Chem. 2016 Jan 5;88(1):354-80. doi: 10.1021/acs.analchem.5b04077. Epub 2015 Dec 3. Review. No abstract available.

39.

Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells.

Wang YC, Stein JW, Lynch CL, Tran HT, Lee CY, Coleman R, Hatch A, Antontsev VG, Chy HS, O'Brien CM, Murthy SK, Laslett AL, Peterson SE, Loring JF.

Sci Rep. 2015 Aug 25;5:13317. doi: 10.1038/srep13317.

40.

Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.

Murthy SK, Greenberg GR, Croitoru K, Nguyen GC, Silverberg MS, Steinhart AH.

Inflamm Bowel Dis. 2015 Sep;21(9):2090-6. doi: 10.1097/MIB.0000000000000474.

PMID:
26099066
41.

Cell chemotaxis on paper for diagnostics.

Walsh DI 3rd, Lalli ML, Kassas JM, Asthagiri AR, Murthy SK.

Anal Chem. 2015 Jun 2;87(11):5505-10. doi: 10.1021/acs.analchem.5b00726. Epub 2015 May 18.

PMID:
25938457
42.

Increased Risk of Venous Thromboembolic Events With Corticosteroid Versus Biologic Therapy for Inflammatory Bowel Disease.

Murthy SK, Nguyen GC.

Clin Gastroenterol Hepatol. 2016 Jan;14(1):166-7. doi: 10.1016/j.cgh.2015.04.022. Epub 2015 Apr 27. No abstract available.

PMID:
25929541
43.

Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics.

Kreimer S, Belov AM, Ghiran I, Murthy SK, Frank DA, Ivanov AR.

J Proteome Res. 2015 Jun 5;14(6):2367-84. doi: 10.1021/pr501279t. Epub 2015 May 14. Review.

PMID:
25927954
44.

Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axis.

Diaz MF, Li N, Lee HJ, Adamo L, Evans SM, Willey HE, Arora N, Torisawa YS, Vickers DA, Morris SA, Naveiras O, Murthy SK, Ingber DE, Daley GQ, García-Cardeña G, Wenzel PL.

J Exp Med. 2015 May 4;212(5):665-80. doi: 10.1084/jem.20142235. Epub 2015 Apr 13.

45.

An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.

Li S, Plouffe BD, Belov AM, Ray S, Wang X, Murthy SK, Karger BL, Ivanov AR.

Mol Cell Proteomics. 2015 Jun;14(6):1672-83. doi: 10.1074/mcp.M114.045724. Epub 2015 Mar 9.

46.

Tunable electrophoretic separations using a scalable, fabric-based platform.

Narahari T, Dendukuri D, Murthy SK.

Anal Chem. 2015 Feb 17;87(4):2480-7. doi: 10.1021/ac5045127. Epub 2015 Jan 27.

PMID:
25582166
47.

Pathway analysis and transcriptomics improve protein identification by shotgun proteomics from samples comprising small number of cells--a benchmarking study.

Sun J, Zhang GL, Li S, Ivanov AR, Fenyo D, Lisacek F, Murthy SK, Karger BL, Brusic V.

BMC Genomics. 2014;15 Suppl 9:S1. doi: 10.1186/1471-2164-15-S9-S1. Epub 2014 Dec 8.

48.

Fundamentals and application of magnetic particles in cell isolation and enrichment: a review.

Plouffe BD, Murthy SK, Lewis LH.

Rep Prog Phys. 2015 Jan;78(1):016601. doi: 10.1088/0034-4885/78/1/016601. Epub 2014 Dec 4. Review.

49.

Perspective on microfluidic cell separation: a solved problem?

Plouffe BD, Murthy SK.

Anal Chem. 2014 Dec 2;86(23):11481-8. doi: 10.1021/ac5013283. Epub 2014 Nov 10. Review.

50.

Microfluidic Isolation of CD34-Positive Skin Cells Enables Regeneration of Hair and Sebaceous Glands In Vivo.

Zhu B, Nahmias Y, Yarmush ML, Murthy SK.

Stem Cells Transl Med. 2014 Nov;3(11):1354-62. doi: 10.5966/sctm.2014-0098. Epub 2014 Sep 9.

Supplemental Content

Loading ...
Support Center